Crossmark

Effect of Concomitant Immunomodulator Use by UST–CDST Classification on Clinical Relapse in Crohn’s Disease Patients Treated with Ustekinumab: A Multicenter Study

Crossref DOI link: https://doi.org/10.1007/s10620-026-09760-6

Published Online: 2026-02-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Song, Joo Hye

Seong, Gyeol

Shin, Jongbeom

Kong, Sung Min

Cha, Boram

Kwon, Kye Sook
License Information

Text and Data Mining valid from 2026-02-21

Version of Record valid from 2026-02-21
More Information

Article History

Received: 19 December 2025

Accepted: 10 February 2026

First Online: 21 February 2026

Declarations

:

: The authors declare no competing interests.

: This case study was conducted in accordance with the tenets of the Declaration of Helsinki and was approved by the Institutional Review Board of Inha University Hospital (IUH 2025-11-018).

Document is current

Any future updates will be listed below